These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 9462253

  • 1. Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.
    Ikeda S, Chisuwa H, Kawasaki S, Ozawa J, Hoshii Y, Yokota T, Aoi T.
    J Clin Pathol; 1997 Nov; 50(11):965-7. PubMed ID: 9462253
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.
    Ordi J, Grau JM, Junqué A, Nomdedeu B, Palacin A, Cardesa A.
    Am J Clin Pathol; 1993 Oct; 100(4):394-7. PubMed ID: 8213634
    [Abstract] [Full Text] [Related]

  • 4. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease.
    Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB.
    QJM; 2002 Apr; 95(4):211-8. PubMed ID: 11937647
    [Abstract] [Full Text] [Related]

  • 5. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease.
    Perfetti V, Bellotti V, Maggi A, Arbustini E, De Benedetti F, Paulli M, Marinone MG, Merlini G.
    Am J Hematol; 1994 Jul; 46(3):189-93. PubMed ID: 7910717
    [Abstract] [Full Text] [Related]

  • 6. Secondary amyloidosis associated with Castleman's disease.
    Tanaka K, Horita M, Shibayama H, Seike M, Itoh Y, Hamaguchi K, Sato Y, Sakata T, Ishida T.
    Intern Med; 1995 Feb; 34(2):122-6. PubMed ID: 7727877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.
    Morita-Hoshi Y, Tohda S, Miura O, Nara N.
    Int J Hematol; 2008 Jan; 87(1):69-74. PubMed ID: 18224416
    [Abstract] [Full Text] [Related]

  • 10. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K.
    Blood; 2000 Jan 01; 95(1):56-61. PubMed ID: 10607684
    [Abstract] [Full Text] [Related]

  • 11. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
    Ishii T, Tatekawa T, Koseto M, Ishii M, Kobayashi H, Koike M, Fujii T, Saeki Y.
    Eur J Haematol; 2003 Feb 01; 70(2):115-8. PubMed ID: 12581193
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fatal diarrhea in a patient with Castleman's disease associated with intestinal amyloidosis.
    Miura A, Sato I, Suzuki C.
    Intern Med; 1995 Nov 01; 34(11):1106-9. PubMed ID: 8774974
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Remission of nephrotic syndrome after removal of localized Castleman's disease.
    Keven K, Nergizoğlu G, Ateş K, Erekul S, Orhan D, Ertürk S, Tulunay O, Karatan O, Ertuğ AE.
    Am J Kidney Dis; 2000 Jun 01; 35(6):1207-11. PubMed ID: 10845836
    [Abstract] [Full Text] [Related]

  • 16. Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.
    Yamagata N, Fujio J, Hirai R, Matsumaru M, Tanimura S, Inokuchi C, Shikai T, Takezako N, Nasu M, Sakata Y, Sata N, Nagai H, Saito K, Miwa A.
    Int J Hematol; 2006 Jul 01; 84(1):70-3. PubMed ID: 16867906
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6-producing thymic squamous cell carcinoma associated with Castleman's disease and nephrotic syndrome.
    Matsumura N, Shiiki H, Saito N, Uramoto H, Hanatani M, Nonaka H, Nakamura S.
    Intern Med; 2002 Oct 01; 41(10):871-4. PubMed ID: 12413013
    [Abstract] [Full Text] [Related]

  • 18. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP, Wegelius O.
    Int J Tissue React; 1985 Oct 01; 7(5):405-7. PubMed ID: 4055265
    [Abstract] [Full Text] [Related]

  • 19. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN.
    Lancet; 2001 Jul 07; 358(9275):24-9. PubMed ID: 11454373
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.